Swiss biotech CFO meeting

Monday, October 27, 2025, 9:30 - 17:00

SIX Swiss Exchange, Pfingstweidstrasse 110, 8021 Zürich

We are delighted to invite you to our annual informal peer-to-peer Swiss biotech CFO meeting.

In this relaxed and interactive setting, you are encouraged to openly share and discuss your unique requirements as a CFO/finance specialist in the biotech sector.

We exchange ideas, share valuable experiences, and collaboratively shape the ideal framework conditions to raise financial resources and enable partnering for biotechs.

Your participation and input are vital for the event’s success. We warmly welcome you to share your ideas to help shape our program further as you register below.

Morning session

Afternoon session

9:30
Welcome coffee and introduction by the Swiss Biotech Association &
Zurich Chamber of Commerce

14:00 – 14:15

Swiss Biotech Association’s contribution to the Swiss biotech community

10:20 – 11:15
Panel discussion moderated by Maximilien Murone

Non-dilutive & philanthropic funding

Gillianne Bowman, Grant Manager & Euresearch Company Advisor, Euresearch
Prabitha Urwyler, Program Manager Bilateral Cooperation, Innosuisse/Eureka
Lucas Tschan, Head Advisory, iGravity
Kostas Kaloulis, Founder & Board Member, ReMedys Foundation

14:15 – 15:00
Selected cases/financing rounds from the Swiss biotech ecosystem around:

Collaborations and deals with Japanese pharma

Djordje Filipovic, CEO, AB2 Bio
Agreement with Nippon Shinyaku
Hernan Levett, CFO, BioVersys
Shionogi deal
Dragan Grabulovski, CEO, Araris Biotech
Taiho Pharmaceutical deal

11:15 – 11:30

Deep Tech Nation Switzerland

Update 2025 by Dario My, Head Venture Hub Switzerland, Deep Tech Nation Switzerland

15:00 – 15:30

Fundraising in the current biotech environment

Emanuele Ostuni, CEO, ArtBio
Daniela Marino, CEO, Cutiss

11:30 – 12:30
Panel discussion moderated by Maximilien Murone

Investors panel

Additional panellists to be confirmed…

Stefan Faes, CFO, BiomedVC
Georg Wiebecke, Angel Investor, BioValley Basel
Karen Wendt, President, Swiss Fintech Ladies
Jean-Marc Le Doussal, CEO, Remora Biotech

15:30 – 16:00

Feedback from the trenches with interactive audience polling

12:30 – 14:00
Networking lunch featuring themed tables dedicated to one of the day’s key topics

16:00 – 17:00
Networking apero